Page last updated: 2024-08-22

clodronic acid and Neoplasms

clodronic acid has been researched along with Neoplasms in 53 studies

Research

Studies (53)

Timeframe	Studies, this research(%)	All Research%
pre-1990	16 (30.19)	18.7374
1990's	17 (32.08)	18.2507
2000's	14 (26.42)	29.6817
2010's	6 (11.32)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J	1
Brignole, C; Di Paolo, D; Pastorino, F; Perri, P; Ponzoni, M	1
Chen, IH; Chong, P; Liu, SJ; Shen, KY; Song, YC	1
Banciu, M; Schiffelers, RM; Storm, G	1
Beckett, MA; Cohen, KS; Liang, H; Mauceri, HJ; Meng, Y; van Rooijen, N; Weichselbaum, RR	1
Åkerud, P; Botling, J; Buysschaert, I; Carmeliet, P; Claesson-Welsh, L; Costa, S; Coulon, C; De Mol, M; De Palma, M; Dewerchin, M; Dresselaer, T; Himmelreich, U; Johansson, I; Knevels, E; Laoui, D; Larsson, E; Li, X; Mazzone, M; Phillipson, M; Rolny, C; Salomäki, H; Segura, I; Squadrito, ML; Tugues, S; Van Ginderachter, JA; Vinckier, S; Wyns, S	1
Chen, X; Li, Q; Qin, L; Wang, B; Wang, J; Zhao, S	1
Allavena, P; Mantovani, A	1
Brandi, ML; Ghinoi, V	1
Berenson, JR	1
Hanson, J; Neumann, C; Quan, HK; Roemer-Bécuwe, C; Romano, F; Vigano, A; Walker, P	1
Atula, ST; Nevalainen, JI; Pylkkänen, LH; Tähtelä, RK	1
Conroy, M; Cree, IA; Fernando, A; Knight, LA; Kurbacher, CM; Polak, M	1
Ballmer-Hofer, K; Marty, C; Odermatt, B; Schwendener, RA; Zehnder-Fjällman, AH; Zeisberger, SM	1
Alajez, NM; Bastianutto, C; Busson, P; Li, JH; Liu, FF; Lo, KW; Lunt, SJ; Milosevic, M; Mocanu, JD; Moriyama, EH; Shi, W; van Rooijen, N; Wilson, BC; Yip, KW	1
Fotovati, A; Hosoi, F; Iguchi, H; Izumi, H; Kimura, YN; Kohno, K; Kuwano, M; Ono, M; Shirouzu, K; Takamori, S; Umezawa, K; Watari, K; Yasumoto, K	1
Cantatore, FP; Longo, V; Mangieri, D; Maruotti, N; Nico, B; Ribatti, D; Vacca, A	1
Douglas, DL; Duckworth, T; Kanis, JA; Prenton, MA; Preston, CJ; Preston, FE; Russell, RG; Woodhead, JS	1
Goa, KL; Plosker, GL	1
Blomqvist, C; Elomaa, I	1
Chang, CC; Su, RJ; Tsai, KS	1
Kiełbiński, M	1
Eyres, K; Fern, D; Kanis, JA; McCloskey, EV; O'Rourke, NP; Vasikaran, S	1
Ralston, SH	1
Burckhardt, P; Fioroni, P; Juillerat, L; Leuenberger, P; Ludwig, H; Markert, M; Pecherstorfer, M; Sauty, A; Thiebaud, D; Zimmer-Roth, I	1
Bruera, E; Hanson, J; Lawlor, P; Pereira, J; Walker, P; Watanabe, S	1
Acito, L; Bracci, R; Carle, F; Cellerino, R; Di Furia, L; Ferretti, B; Nortilli, R; Pancotti, A; Piga, A; Sandri, P	1
Mundy, GR	1
Brion, N; Clerc, D; Paule, B	1
Body, JJ	1
A'Hern, R; Broadley, K; Davis, C; Gwilliam, B; Hardy, J; Ling, J; Rees, E; Shah, S	1
Barras, C; Courvoisier, B; Jung, A; Mermillod, B	1
Bonjour, JP; Buchs, B; Rizzoli, R	1
Coleman, RE	1
Bonjour, JP; Rizzoli, R	1
Kanis, JA; McCloskey, EV; Paterson, AH	1
Boyle, IT; Dryburgh, FJ; Fraser, WD; Gallacher, SJ; Patel, U; Ralston, SH	1
Fritze, D; Harjung, H	1
Ljunghall, S	1
Scharla, SH; Ziegler, R	1
Boyle, IT; Cowan, RA; Dryburgh, FJ; Fraser, WD; Gallacher, SJ; Patel, U; Ralston, SH	1
Benson, AB; Citrin, DL; Davis, TE; Durie, BG; Jacobs, TP; Koeller, J; Lipton, A; Stock, JL; Witte, RS	1
Akerström, G; Benson, L; Johansson, H; Knuutila, M; Ljunghall, S; Pettersson, B; Rastad, J; Wallfelt, C	1
Blind, E; Ho, T; Mende, U; Minne, HW; Sattar, P; Scharla, SH; Schmidt-Gayk, H; Wüster, C; Ziegler, R	1
Peck, WA	1
Gray, RE; Greaves, M; Hamdy, NA; Kanis, JA; McCloskey, EV; Neil, FE; Preston, FE; Urwin, GH; Yates, AJ	1
Canfield, RE; Jacobs, TP; Siris, ES	1
Akerström, G; Ljunghall, S; Rastad, J	1
Lind, L; Ljunghall, S; Wengle, B	1
Bisetti, A; Bonjour, JP; Guelpa, G; Jung, A; Kanis, JA; Philippe, J; Rizzoli, R; Rosini, S	1
Adami, S; Bertoldo, F; Bolzicco, GP; Lo Cascio, V; Rizzo, A; Rossini, M; Salvagno, G; Suppi, R	1
Caberlotto, L; Conte, N; Di Virgilio, R; Roiter, I	1

Reviews

12 review(s) available for clodronic acid and Neoplasms

Article	Year
Targeting Macrophages as a Potential Therapeutic Intervention: Impact on Inflammatory Diseases and Cancer. International journal of molecular sciences, 2018, Jul-04, Volume: 19, Issue:7 Topics: Animals; Clodronic Acid; Disease Models, Animal; Drug Delivery Systems; Humans; Inflammation; Liposomes; Macrophages; Mice; Nanotechnology; Neoplasms	2018
Immunology in the clinic review series; focus on cancer: tumour-associated macrophages: undisputed stars of the inflammatory tumour microenvironment. Clinical and experimental immunology, 2012, Volume: 167, Issue:2 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzenesulfonates; Chemotaxis; Clodronic Acid; Cytokines; Dioxoles; Disease Progression; Humans; Immunity, Innate; Inflammation; Liposomes; Macrophages; Mice; Molecular Targeted Therapy; Neoplasm Invasiveness; Neoplasm Proteins; Neoplasms; Neovascularization, Pathologic; Niacinamide; Phenylurea Compounds; Prognosis; Pyridines; Sorafenib; Tetrahydroisoquinolines; Trabectedin; Tumor Escape; Tumor Microenvironment	2012
Clodronate: mechanisms of action on bone remodelling and clinical use in osteometabolic disorders. Expert opinion on pharmacotherapy, 2002, Volume: 3, Issue:11 Topics: Antimetabolites; Bone and Bones; Bone Diseases; Bone Remodeling; Clinical Trials as Topic; Clodronic Acid; Drug Evaluation, Preclinical; Humans; Hyperkalemia; Hyperparathyroidism; Neoplasms; Osteitis Deformans; Osteoporosis	2002
Treatment of hypercalcemia of malignancy with bisphosphonates. Seminars in oncology, 2002, Volume: 29, Issue:6 Suppl 21 Topics: Bone Resorption; Clinical Trials as Topic; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Hypercalcemia; Ibandronic Acid; Imidazoles; Neoplasms; Pamidronate; Zoledronic Acid	2002
Clodronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease. Drugs, 1994, Volume: 47, Issue:6 Topics: Animals; Bone Neoplasms; Bone Resorption; Calcinosis; Clinical Trials as Topic; Clodronic Acid; Dose-Response Relationship, Drug; Half-Life; Humans; Hydroxyproline; Hypercalcemia; Infusions, Intravenous; Metabolic Clearance Rate; Neoplasms; Osteitis Deformans; Osteoporosis; Tissue Distribution	1994
Clodronate and other bisphosphonates as supportive therapy in osteolysis due to malignancy. Acta oncologica (Stockholm, Sweden), 1995, Volume: 34, Issue:5 Topics: Clodronic Acid; Diphosphonates; Humans; Neoplasms; Osteolysis	1995
[Pharmacologic therapy of bone tissue changes due to hematologic malignancies and bone metastasis]. Acta haematologica Polonica, 1994, Volume: 25, Issue:2 Topics: Bone Neoplasms; Calcitonin; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Neoplasms; Osteolysis; Osteosclerosis; Pamidronate	1994
Pathogenesis and management of cancer associated hypercalcaemia. Cancer surveys, 1994, Volume: 21 Topics: Antineoplastic Agents; Calcitonin; Calcium; Clodronic Acid; Diphosphonates; Diuretics; Etidronic Acid; Fluid Therapy; Gallium; Humans; Hypercalcemia; Neoplasms; Pamidronate; Phosphates; Plicamycin; Research	1994
Bisphosphonates as cancer drugs. Hospital practice (1995), 1999, May-15, Volume: 34, Issue:5 Topics: Antineoplastic Agents; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Neoplasm Proteins; Neoplasms; Osteolysis; Pamidronate; Parathyroid Hormone-Related Protein; Proteins; Risedronic Acid; Transforming Growth Factor beta	1999
Current and future directions in medical therapy: hypercalcemia. Cancer, 2000, Jun-15, Volume: 88, Issue:12 Suppl Topics: Clodronic Acid; Diphosphonates; Humans; Hypercalcemia; Ibandronic Acid; Imidazoles; Neoplasms; Pamidronate; Zoledronic Acid	2000
Treatment of hypercalcaemia of malignancy with clodronate. Bone, 1991, Volume: 12 Suppl 1 Topics: Calcium; Clodronic Acid; Homeostasis; Humans; Hypercalcemia; Neoplasms; Osteoclasts; Osteolysis	1991
Use of clodronate and calcitonin in hypercalcemia due to malignancy. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1989, Volume: 116 Topics: Calcitonin; Clodronic Acid; Diphosphonates; Humans; Hypercalcemia; Neoplasms	1989

Trials

9 trial(s) available for clodronic acid and Neoplasms

Article	Year
Clodronate as a single-dose intravenous infusion effectively provides short-term correction of malignant hypercalcemia. Acta oncologica (Stockholm, Sweden), 2003, Volume: 42, Issue:7 Topics: Calcium; Clodronic Acid; Diphosphonates; Double-Blind Method; Female; Humans; Hypercalcemia; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Pamidronate	2003
Interleukin-6 and tumor necrosis factor alpha levels after bisphosphonates treatment in vitro and in patients with malignancy. Bone, 1996, Volume: 18, Issue:2 Topics: Aged; Aged, 80 and over; Bone Resorption; Clodronic Acid; Diphosphonates; Female; Follow-Up Studies; Humans; Ibandronic Acid; Interleukin-1; Interleukin-6; Male; Middle Aged; Neoplasms; Pamidronate; Tumor Necrosis Factor-alpha	1996
A double blind randomized study of oral clodronate in the treatment of bone metastases from tumors poorly responsive to chemotherapy. Journal of experimental & clinical cancer research : CR, 1998, Volume: 17, Issue:2 Topics: Administration, Oral; Aged; Antineoplastic Agents; Bone Neoplasms; Clodronic Acid; Double-Blind Method; Humans; Infant, Newborn; Middle Aged; Neoplasms; Placebos	1998
Is there a dose response relationship for clodronate in the treatment of tumour induced hypercalcaemia? British journal of cancer, 2002, Apr-22, Volume: 86, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Calcium; Clodronic Acid; Dose-Response Relationship, Drug; Female; Humans; Hypercalcemia; Male; Middle Aged; Neoplasms	2002
Effect of a single infusion of alendronate in malignant hypercalcaemia: dose dependency and comparison with clodronate. International journal of cancer, 1992, Mar-12, Volume: 50, Issue:5 Topics: Aged; Alendronate; Bone Resorption; Calcium; Clodronic Acid; Diphosphonates; Dose-Response Relationship, Drug; Female; Humans; Hypercalcemia; Male; Middle Aged; Neoplasms	1992
Comparison of three intravenous bisphosphonates in cancer-associated hypercalcaemia. Lancet (London, England), 1989, Nov-18, Volume: 2, Issue:8673 Topics: Administration, Oral; Bone Resorption; Calcium; Clodronic Acid; Diphosphonates; Drug Administration Schedule; Drug Evaluation; Etidronic Acid; Humans; Infusions, Intravenous; Middle Aged; Neoplasms; Pamidronate; Randomized Controlled Trials as Topic; Recurrence; Time Factors	1989
Clodronate. A randomized study in the treatment of cancer-related hypercalcemia. Archives of internal medicine, 1987, Volume: 147, Issue:5 Topics: Adult; Aged; Clinical Trials as Topic; Clodronic Acid; Diphosphonates; Double-Blind Method; Female; Humans; Hypercalcemia; Male; Middle Aged; Neoplasms; Random Allocation; Saline Solution, Hypertonic	1987
Results of a randomized study of clodronate in treating cancer-related hypercalcemia. Archives of internal medicine, 1987, Volume: 147, Issue:11 Topics: Clinical Trials as Topic; Clodronic Acid; Diphosphonates; Humans; Hypercalcemia; Leukemia; Neoplasms; Random Allocation	1987
Dichloromethylene diphosphonate action in hematologic and other malignancies. Bone, 1987, Volume: 8 Suppl 1 Topics: Administration, Oral; Bone and Bones; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Clinical Trials as Topic; Clodronic Acid; Diphosphonates; Female; Humans; Hydroxyproline; Hypercalcemia; Infusions, Intravenous; Leukemia, Lymphoid; Male; Multiple Myeloma; Neoplasms; Pain	1987

Other Studies

32 other study(ies) available for clodronic acid and Neoplasms

Article	Year
Chemical genetics reveals a complex functional ground state of neural stem cells. Nature chemical biology, 2007, Volume: 3, Issue:5 Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells	2007
Depletion of tumor-associated macrophages enhances the anti-tumor immunity induced by a Toll-like receptor agonist-conjugated peptide. Human vaccines & immunotherapeutics, 2014, Volume: 10, Issue:11 Topics: Animals; Antibodies, Blocking; Clodronic Acid; Cyclooxygenase 2 Inhibitors; Dendritic Cells; Immunization; Immunotherapy; Lipopeptides; Lipoylation; Lymphocyte Activation; Macrophages; Mice; Mice, Inbred C57BL; Neoplasms; Palmitic Acid; Papillomavirus E7 Proteins; Receptors, Interleukin-10; Survival Rate; T-Lymphocytes, Cytotoxic; Toll-Like Receptor 2; Toll-Like Receptor 6	2014
Investigation into the role of tumor-associated macrophages in the antitumor activity of Doxil. Pharmaceutical research, 2008, Volume: 25, Issue:8 Topics: Angiogenesis Inhibitors; Angiogenic Proteins; Animals; Antineoplastic Agents; Cell Line, Tumor; Clodronic Acid; Doxorubicin; Drug Carriers; Injections, Intravenous; Liposomes; Macrophages; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasms	2008
Blockade of tumor necrosis factor alpha signaling in tumor-associated macrophages as a radiosensitizing strategy. Cancer research, 2010, Feb-15, Volume: 70, Issue:4 Topics: Animals; Cell Proliferation; Clodronic Acid; Drug Evaluation, Preclinical; Etanercept; Immunoglobulin G; Liposomes; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Neoplasms; Radiation Tolerance; Radiation-Sensitizing Agents; Receptors, Tumor Necrosis Factor; Signal Transduction; Tumor Burden; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A	2010
HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF. Cancer cell, 2011, Jan-18, Volume: 19, Issue:1 Topics: Animals; Antibodies; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Cell Proliferation; Chemotactic Factors; Clodronic Acid; Culture Media, Conditioned; Cytokines; Dendritic Cells; Down-Regulation; Endothelial Cells; Gene Expression; Humans; Hypoxia; Lung Neoplasms; Macrophages; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Microvessels; Neoplasm Metastasis; Neoplasms; Neovascularization, Pathologic; Placenta Growth Factor; Pregnancy Proteins; Proteins; Regional Blood Flow; Transfection	2011
Transition of tumor-associated macrophages from MHC class II(hi) to MHC class II(low) mediates tumor progression in mice. BMC immunology, 2011, Aug-04, Volume: 12 Topics: Adoptive Transfer; Animals; Cell Line, Tumor; Clodronic Acid; Cytokines; Disease Progression; Female; Histocompatibility Antigens Class II; Leukocyte Reduction Procedures; Liposomes; Lymphocyte Activation; Macrophages; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neoplasm Invasiveness; Neoplasms; T-Lymphocytes; Tumor Microenvironment	2011
Safety of subcutaneous clodronate and efficacy in hypercalcemia of malignancy: a novel route of administration. Journal of pain and symptom management, 2003, Volume: 26, Issue:3 Topics: Analgesics, Non-Narcotic; Clodronic Acid; Cohort Studies; Female; Humans; Hypercalcemia; Injections, Subcutaneous; Male; Neoplasms; Retrospective Studies; Treatment Outcome	2003
Pilot studies of the effect of zoledronic acid (Zometa) on tumor-derived cells ex vivo in the ATP-based tumor chemosensitivity assay. Anti-cancer drugs, 2005, Volume: 16, Issue:9 Topics: Adenosine Triphosphate; Adult; Aged; Aged, 80 and over; Alendronate; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Caspase 3; Caspase 7; Caspases; Cell Line, Tumor; Cell Survival; Cisplatin; Clodronic Acid; Diphosphonates; Energy Metabolism; Female; Humans; Imidazoles; Inhibitory Concentration 50; Lung Neoplasms; Male; Melanoma; Middle Aged; Neoplasms; Neoplasms, Unknown Primary; Ovarian Neoplasms; Paclitaxel; Tumor Cells, Cultured; Zoledronic Acid	2005
Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach. British journal of cancer, 2006, Aug-07, Volume: 95, Issue:3 Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Clodronic Acid; Female; Humans; Immunohistochemistry; In Vitro Techniques; Liposomes; Macrophages; Mice; Mice, Nude; Neoplasms; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays	2006
Imaging the modulation of adenoviral kinetics and biodistribution for cancer gene therapy. Molecular therapy : the journal of the American Society of Gene Therapy, 2007, Volume: 15, Issue:5 Topics: Adenoviridae; Animals; Antineoplastic Agents; Benzamides; Cell Line, Tumor; Clodronic Acid; Genetic Therapy; Genetic Vectors; Humans; Imatinib Mesylate; Immunohistochemistry; Kinetics; Liver; Luciferases; Luminescent Measurements; Male; Mice; Mice, SCID; Microscopy, Fluorescence; Neoplasms; Phosphorylation; Piperazines; Pyrimidines; Receptor, Platelet-Derived Growth Factor beta; Recombinant Fusion Proteins; Reverse Transcriptase Polymerase Chain Reaction; Time Factors; Tissue Distribution	2007
Inflammatory stimuli from macrophages and cancer cells synergistically promote tumor growth and angiogenesis. Cancer science, 2007, Volume: 98, Issue:12 Topics: Animals; Cell Division; Cell Line, Tumor; Clodronic Acid; Drug Synergism; Humans; Inflammation; Interleukin-1beta; Lung Neoplasms; Macrophages; Male; Mice; Mice, Inbred C57BL; Neoplasms; Neovascularization, Pathologic; Transplantation, Heterologous; U937 Cells	2007
Clodronate inhibits angiogenesis in vitro and in vivo. Oncology reports, 2008, Volume: 19, Issue:5 Topics: Angiogenesis Inhibitors; Animals; Bone Density Conservation Agents; Capillaries; Cell Proliferation; Chick Embryo; Chorioallantoic Membrane; Clodronic Acid; Collagen; Drug Combinations; Endothelium, Vascular; Fibroblast Growth Factor 2; In Vitro Techniques; Inflammation; Laminin; Microscopy, Phase-Contrast; Neoplasms; Neovascularization, Pathologic; Proteoglycans	2008
Effect of dichloromethylene diphosphonate in Paget's disease of bone and in hypercalcaemia due to primary hyperparathyroidism or malignant disease. Lancet (London, England), 1980, May-17, Volume: 1, Issue:8177 Topics: Alkaline Phosphatase; Bone Resorption; Calcium; Clodronic Acid; Diphosphonates; Humans; Hydroxyproline; Hypercalcemia; Hyperparathyroidism; Neoplasms; Osteitis Deformans	1980
Plasma PTH and PTH-rP levels and clodronate therapy in cancer patients with hypercalcemia. Journal of the Formosan Medical Association = Taiwan yi zhi, 1993, Volume: 92, Issue:11 Topics: Clodronic Acid; Humans; Hypercalcemia; Neoplasms; Parathyroid Hormone; Parathyroid Hormone-Related Protein; Proteins	1993
Effective treatment of malignant hypercalcaemia with a single intravenous infusion of clodronate. British journal of cancer, 1993, Volume: 67, Issue:3 Topics: Adult; Aged; Calcium; Clodronic Acid; Drug Administration Schedule; Female; Humans; Hypercalcemia; Infusions, Intravenous; Male; Middle Aged; Neoplasms	1993
Subcutaneous clodronate: a study evaluating efficacy in hypercalcemia of malignancy and local toxicity. Annals of oncology : official journal of the European Society for Medical Oncology, 1997, Volume: 8, Issue:9 Topics: Aged; Aged, 80 and over; Clodronic Acid; Female; Humans; Hypercalcemia; Injections, Subcutaneous; Male; Middle Aged; Neoplasms	1997
[Biosphonates in oncology]. Presse medicale (Paris, France : 1983), 2000, Apr-08, Volume: 29, Issue:13 Topics: Bone Neoplasms; Clodronic Acid; Diphosphonates; Fractures, Bone; Humans; Neoplasms; Osteolysis; Pain; Pamidronate; Spinal Cord Compression	2000
[Effect of 2 phosphonates on the osteolysis induced by tumor extracts]. Schweizerische medizinische Wochenschrift, 1979, Dec-08, Volume: 109, Issue:47 Topics: Animals; Animals, Newborn; Clodronic Acid; Diphosphonates; Etidronic Acid; Mice; Neoplasm Metastasis; Neoplasms; Osteolysis; Skull; Tissue Extracts	1979
Supportive care drug studies: some promising, some not. Oncology (Williston Park, N.Y.), 1992, Volume: 6, Issue:9 Topics: Amifostine; Antineoplastic Agents; Cachexia; Clodronic Acid; Fractures, Spontaneous; Humans; Hydrazines; Neoplasms	1992
Bisphosphonate treatment of bone metastases and hypercalcemia of malignancy. Oncology (Williston Park, N.Y.), 1991, Volume: 5, Issue:8 Topics: Animals; Bone and Bones; Bone Neoplasms; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Hypercalcemia; Neoplasms; Pamidronate	1991
Use of diphosphonates in hypercalcaemia due to malignancy. Lancet (London, England), 1990, Jan-20, Volume: 335, Issue:8682 Topics: Clodronic Acid; Diphosphonates; Humans; Hypercalcemia; Neoplasms	1990
Use of bisphosphonates in hypercalcaemia due to malignancy. Lancet (London, England), 1990, Mar-24, Volume: 335, Issue:8691 Topics: Clodronic Acid; Diphosphonates; Humans; Hypercalcemia; Neoplasms; Pamidronate	1990
[Monotherapy with clodronate for tumor-induced hypercalcemia]. Deutsche medizinische Wochenschrift (1946), 1990, Jan-12, Volume: 115, Issue:2 Topics: Aged; Breast Neoplasms; Carcinoma; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Clodronic Acid; Diphosphonates; Female; Humans; Hypercalcemia; Leiomyosarcoma; Lung Neoplasms; Male; Middle Aged; Neoplasms; Pancreatic Neoplasms; Plasmacytoma; Uterine Neoplasms	1990
Treatment of tumor hypercalcemia with clodronate. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1989, Volume: 116 Topics: Administration, Oral; Adult; Aged; Calcitriol; Calcium; Clodronic Acid; Creatinine; Diphosphonates; Drug Evaluation; Humans; Hypercalcemia; Infusions, Intravenous; Middle Aged; Neoplasms; Parathyroid Hormone	1989
Clodronate treatment in patients with malignancy-associated hypercalcemia. Acta medica Scandinavica, 1987, Volume: 221, Issue:5 Topics: Administration, Oral; Adult; Aged; Clodronic Acid; Diphosphonates; Female; Humans; Hypercalcemia; Injections, Intravenous; Male; Middle Aged; Neoplasms	1987
[Treatment of tumor hypercalcemia with clodronate. Effect on parathormone and calcitriol]. Deutsche medizinische Wochenschrift (1946), 1987, Jul-10, Volume: 112, Issue:28-29 Topics: Adult; Aged; Calcitriol; Clodronic Acid; Diphosphonates; Female; Humans; Hypercalcemia; Male; Middle Aged; Neoplasms; Parathyroid Hormone	1987
Treatment of the hypercalcaemia of malignancy with intravenous clodronate. Bone, 1987, Volume: 8 Suppl 1 Topics: Adult; Aged; Bone Resorption; Calcium; Clodronic Acid; Diphosphonates; Female; Humans; Hydroxyproline; Hypercalcemia; Infusions, Intravenous; Kidney Tubules; Leukemia; Male; Middle Aged; Neoplasms	1987
Comparative effects of calcitonin and clodronate in hypercalcaemia. Bone, 1987, Volume: 8 Suppl 1 Topics: Administration, Oral; Calcitonin; Clodronic Acid; Diphosphonates; Follow-Up Studies; Humans; Hypercalcemia; Infusions, Intravenous; Neoplasms; Time Factors	1987
Treatment with clodronate in patients with hypercalcemia secondary to malignancy. Upsala journal of medical sciences, 1987, Volume: 92, Issue:3 Topics: Adult; Aged; Clodronic Acid; Diphosphonates; Female; Humans; Hypercalcemia; Male; Middle Aged; Neoplasms	1987
Bone and renal components in hypercalcemia of malignancy and responses to a single infusion of clodronate. Bone, 1988, Volume: 9, Issue:3 Topics: Bone Resorption; Calcium; Clodronic Acid; Diphosphonates; Humans; Hypercalcemia; Kidney Tubules; Neoplasms	1988
The use of dichloromethylene bisphosphonate and aminobutane bisphosphonate in hypercalcemia of malignancy. Bone and mineral, 1987, Volume: 2, Issue:5 Topics: Administration, Oral; Adult; Aged; Clodronic Acid; Diphosphonates; Female; Humans; Hypercalcemia; Infusions, Intravenous; Injections, Intramuscular; Male; Middle Aged; Neoplasms; Recurrence	1987
Hypercalcemia in malignancies: treatment with dichloromethylene diphosphonate (Cl2MDP). Tumori, 1985, Feb-28, Volume: 71, Issue:1 Topics: Adult; Aged; Bone Neoplasms; Calcium; Clodronic Acid; Diphosphonates; Drug Evaluation; Female; Humans; Hydroxyproline; Hypercalcemia; Male; Middle Aged; Neoplasms; Time Factors	1985